Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Integrating long-acting injectable treatment to improve medication adherence among persons living with HIV and opioid use disorder: study protocol ; volume:18 ; number:1 ; day:14 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Addiction science & clinical practice ; 18, Heft 1 (14.10.2023), 1-11, 12.2023
- Urheber
-
Langdon, Kirsten J.
Hitch, Anthony E.
Collins, Alexandra B.
Beckwith, Curt G.
Becker, Sara
Tashima, Karen
Rich, Josiah D.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-023-00418-6
- URN
-
urn:nbn:de:101:1-2024020613182540737573
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Langdon, Kirsten J.
- Hitch, Anthony E.
- Collins, Alexandra B.
- Beckwith, Curt G.
- Becker, Sara
- Tashima, Karen
- Rich, Josiah D.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
Patients’ goals when initiating long-acting injectable buprenorphine treatment for opioid use disorder: findings from a longitudinal qualitative study
Pharmacokinetics of an injectable long-acting formulation of doxycycline hyclate in dogs
Attitudes of European physicians towards the use of long-acting injectable antipsychotics
Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors
Improvement of long-term outcome in schizophrenia: switching to risperidone long-acting injectable
Long-Acting Injectable Antipsychotics in a Prescription Claims Data Source: A Validation Study
Engagement in Care, Awareness, and Interest in Long-Acting Injectable Anti-Retroviral Therapy
Long-Acting Reversible Contraception